Top 15 drug patent losses for 2013 | Download Table
Teva Capitalizes On Patent Expiry To Launch First Perforomist Rival :: Generics Bulletin
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Patents mean big business to big pharma
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
List - 91 Drug Patents that are Expiring between 2020 to 2022 - GreyB
TEVA PHARMS USA drug pipeline, international patents
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute | Reuters
The biggest drug patent losses for 2013 - GaBI Journal
Generic Pharmaceuticals Market – Global Industry Size, Share, Analysis & Trends 2023-2032 | BioSpace
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Generic Drugs in the Pipeline: 2017 Update
Pharmaceuticals | Free Full-Text | Biosimilars: Company Strategies to Capture Value from the Biologics Market
Skinny labelling of generics: the beginning of the end for this practice? - Pharma Technology Focus | Issue 104 | March 2021
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
TEVA drug pipeline, global patents
PATENT EXPIRY DATES 1/3 | New Drug Approvals
